435B peptide

General Information


DRACP ID  DRACP05214

Peptide Name   435B peptide

Sequence  GPFHFYQFLFPPV

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  FITC

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C84H106N16O16

Absent amino acids  ACDEIKMNRSTW

Common amino acids  F

Mass  181007

Pl  7.54

Basic residues  1

Acidic residues  0

Hydrophobic residues  6

Net charge  1

Boman Index  1148

Hydrophobicity  46.15

Aliphatic Index  52.31

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  124.17

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 17268054

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  1536

DRACP is developed by Dr.Zheng's team.